Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > EBITDA / Interest Expenses

Aquestive Therapeutics Inc EBITDA / Interest Expenses Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly EBITDA / Interest Expenses from 2017 to 2018. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Aquestive Therapeutics Inc EBITDA / Interest Expenses for the quarter ending March 03, 2018 was $3m
  • Aquestive Therapeutics Inc EBITDA / Interest Expenses for the last 12 months ending March 03, 2018 was $1m
  • Aquestive Therapeutics Inc Annual EBITDA / Interest Expenses for 2017 was $0m a 0.71% increase of 0m from 2016
  • Aquestive Therapeutics Inc Annual EBITDA / Interest Expenses for 2016 was $0m
Other Ratios Metrics:
  • Aquestive Therapeutics Inc Total Debt / Capital for the quarter ending December 12, 2018 was $82m a -136.67% decrease of -113m year over year
  • Aquestive Therapeutics Inc Other Liabilities for the quarter ending December 12, 2018 was $1m a -565.38% decrease of -7m year over year
  • Aquestive Therapeutics Inc Total Debt / Equity for the quarter ending December 12, 2018 was $468m
View Chart On Koyfin

Quarterly AQST EBITDA / Interest Expenses Data

03/2018$3m
09/2017$6m
03/2017$1m

Annual AQST EBITDA / Interest Expenses Data

2017$0m
2016$0m